Delivery Order SPE2DB20D2104-SPE2DB25FMBZJ

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,620,567 units of the generic drug Azathioprine 50 mg tablets, with a ceiling value of $12,589.94 and a completion date of December 6, 2024. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical...
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Azathioprine 50 mg tablets. The award has a ceiling value of $1,309.38 and a performance period through August 20, 2024. This order is placed against an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the DLA to efficiently procure a wide range of medical commodities, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of azathioprine 50 mg tablets. The award has a ceiling value of $3,118.39 and an ultimate completion date of October 9, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, valued at $1,152.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,567,806,722 units of azathioprine 50 mg tablets. The contract has an ultimate completion date of April 7, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,724.08, is for the delivery of 4,561,708,633 units of the medication Azathioprine 50 mg tablets, with a completion date of August 7, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,759.29 and covers the delivery of 4,566,920,843 units of Azathioprine 50 mg tablets. The contract is a Firm Fixed Price, Indefinite Delivery Indefinite Quantity (IDIQ) contract that runs through January 15, 2025. This contract is not designated as a set-aside. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,339.62 firm fixed-price contract is for the delivery of 4,567,822,173 units of the drug Azathioprine 50 mg tablets. The contract has an ultimate completion date of April 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Azathioprine 50 mg tablets. The contract has a ceiling value of $3,036.49 and a period of performance through May 11, 2023. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as Amerisourcebergen, with the DLA Troop Support Medical. The IDC has a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,935.03 awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of AZATHIOPRINE 50 MG TABLET 100S, a pharmaceutical product, with a period of performance through August 1, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of azathioprine 50 mg tablets. The contract has a ceiling value of $1,770.25 and a completion date of January 4, 2024. It is a firm-fixed-price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMBZJ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,712.16, is for the supply of Azathioprine 50 mg tablets to support federal healthcare programs.

The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This contract award does not have a set-aside designation, indicating open competition. The contract was awarded on November 13, 2024, with a completion date of November 14, 2024, and utilizes a Firm Fixed Price pricing type.

Generated 5/20/25, 2:03 PM